Gust KM - Search Results

1

Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?

Soria F, D'Andrea D, Barale M, Gust KM, Pisano F, Mazzoli S, De Bellis M, Rosazza M, Livoti S, Dutto D, Lillaz B, Pradere B, Moschini M, Tamandl D, Shariat SF, Gontero P; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group. Soria F, et al. Among authors: gust km. Eur Urol Open Sci. 2023 Feb 18;50:17-23. doi: 10.1016/j.euros.2023.02.001. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 37101772 Free PMC article.

2

The role of mTOR in bladder cancer.

Gust KM, So AI. Gust KM, et al. Cancer Biol Ther. 2009 Dec;8(24):2348-50. doi: 10.4161/cbt.8.24.10296. Epub 2009 Dec 9. Cancer Biol Ther. 2009. PMID: 19949304 No abstract available.

3

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.

Tsaur I, Hudak L, Makarević J, Juengel E, Mani J, Borgmann H, Gust KM, Schilling D, Bartsch G, Nelson K, Haferkamp A, Blaheta RA. Tsaur I, et al. Among authors: gust km. J Cell Mol Med. 2015 Aug;19(8):1795-804. doi: 10.1111/jcmm.12583. Epub 2015 Mar 26. J Cell Mol Med. 2015. PMID: 25808196 Free PMC article.

4

Phonological deficit in school children is reflected in the Mismatch Negativity.

Bitz U, Gust K, Spitzer M, Kiefer M. Bitz U, et al. Neuroreport. 2007 Jun 11;18(9):911-5. doi: 10.1097/WNR.0b013e32810f2e25. Neuroreport. 2007. PMID: 17515800

5

[GreenLight laser therapy for benign prostatic hyperplasia: dilemma of reimbursement in the DRG system].

Petschl S, Finter F, Gust K, Volkmer BG. Petschl S, et al. Urologe A. 2009 Feb;48(2):177-82. doi: 10.1007/s00120-008-1885-0. Urologe A. 2009. PMID: 18931990 German.

6

[Therapy of overactive bladder (OAB)].

Kurosch M, Mager R, Gust K, Brandt M, Borgmann H, Haferkamp A. Kurosch M, et al. Urologe A. 2015 Apr;54(4):567-74; quiz 575-6. doi: 10.1007/s00120-015-3770-y. Urologe A. 2015. PMID: 25758236 German.

7

[Erratum to: Locally advanced or oligometastatic bladder cancer-role of local treatment of the primary tumor and metastases].

Rebhan K, Gust KM. Rebhan K, et al. Among authors: gust km. Urologie. 2022 Jul;61(7):781. doi: 10.1007/s00120-022-01789-5. Urologie. 2022. PMID: 35230454 German. No abstract available.

8

Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells.

Vallo S, Köpp R, Michaelis M, Rothweiler F, Bartsch G, Brandt MP, Gust KM, Wezel F, Blaheta RA, Haferkamp A, Cinatl J Jr. Vallo S, et al. Among authors: gust km. Oncol Lett. 2017 Jun;13(6):4085-4092. doi: 10.3892/ol.2017.5986. Epub 2017 Apr 5. Oncol Lett. 2017. PMID: 28599410 Free PMC article.

9

[Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth].

Rinnab L, Gust K, Hautmann RE, Küfer R. Rinnab L, et al. Urologe A. 2009 May;48(5):516-22. doi: 10.1007/s00120-009-1954-z. Urologe A. 2009. PMID: 19296069 Review. German.

10

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.

Han KS, Raven PA, Frees S, Gust K, Fazli L, Ettinger S, Hong SJ, Kollmannsberger C, Gleave ME, So AI. Han KS, et al. Neoplasia. 2015 Nov;17(11):805-16. doi: 10.1016/j.neo.2015.11.001. Neoplasia. 2015. PMID: 26678908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page